Breaking into bone biology: target practice

Choi, Yongwon; Walsh, Matthew C; Arron, Joseph R
February 2009
Nature Medicine;Feb2009, Vol. 15 Issue 2, p144
Academic Journal
The article focuses on research on alternative methods to prevent osteoporosis. It states that two cell types play an important role in bone biology: osteoclasts, which resorb bone, and osteoblasts, which build bone up. It mentions that treatments such as biphosphonates work to block bone loss. It comments on the development of drugs to block specifically the termination differential of osteoclasts.


Related Articles

  • Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages. Roelofs, A. J.; Thompson, K.; Ebetino, F. H.; Rogers, M. J.; Coxon, F. P. // Current Pharmaceutical Design;9/11/2010, Vol. 16 Issue 27, p2950 

    No abstract available.

  • The role of bisphosphonates in diseases of childhood. Srivastava, Tarak; Alon, Uri S. // European Journal of Pediatrics;2003, Vol. 162 Issue 11, p735 

    Bisphosphonates are synthetic analogues of pyrophosphate that inhibit bone resorption by their action on osteoclasts. In recent years, bisphosphonates have been used in children for treatment of a growing number of disorders associated primarily with generalized or localized osteoporosis,...

  • Novel Insights into Bone Remodeling: Closing in on New Ways to Fight Osteoporosis and Arthritis. Buckley, Rita // MD Conference Express;Dec2011, p4 

    The article presents insights from Dr. Dallas C. Jones of Harvard Medical School on the importance of bone remodeling to fight osteoporosis and arthritis in the U.S. He states that bone remodeling is a balanced process involving the orchestration of bone cell activities, the removal of old or...

  • Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis. Martin, T. J.; Sims, N. A.; Ng, K. W. // Osteoporosis International;Aug2008, Vol. 19 Issue 8, p1125 

    The understanding of cell interactions and genetic controls of bone cells has provided new approaches to drug development for osteoporosis. Current emphasis in the development of new anabolic therapies is directed at modifying the effects of Wnt signalling on osteoblast differentiation and bone...

  • Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. Allen, Matthew R.; Erickson, Antonia M.; Xiang Wang; Burr, David B.; Martin, R. Bruce; Hazelwood, Scott J.; Wang, Xiang // Calcified Tissue International;Jan2010, Vol. 86 Issue 1, p67 

    Bisphosphonates (BPs) slow bone loss by reducing initiation of new basic multicellular units (BMUs). Whether or not BPs simply prevent osteoclasts from initiating new BMUs that resorb bone or also reduce the amount of bone they resorb at the BMU level is not clear. The goal of this study was to...

  • Image-Based Extracorporeal Tissue Engineering of Individualized Bone Constructs. Meyer, Ulrich; B├╝chter, Andre; Hohoff, Ariane; Stoffels, Elke; Szuwart, Thomas; Runte, Christoph; Dirksen, Dieter; Wiesmann, Hans-Peter // International Journal of Oral & Maxillofacial Implants;Nov/Dec2005, Vol. 20 Issue 6, p882 

    Purpose: Computer-aided technologies have been recently employed for use in extracorporeal bone tissue engineering strategies. In this pilot animal experimental study, the intention was to test whether autologous osteoblast-like cells cultured in vitro on individualized scaffolds can be used to...

  • Dexamethasone Inhibits Formation of Osteoclast-like Cells in Bone-marrow Cultures. PHAROAH, M. J.; HEERSCHE, J. N. M. // Journal of Dental Research;Jul1986, Vol. 65 Issue 7, p1006 

    Our observations confirm the previously reported observation that multinucleated cells develop within a two-week period in cat bone-marrow cultures. Calcitonin induces cytoplasmic contraction in these multinucleated cells, which indicates that they resemble osteoclasts. After seven days of...

  • Endocytosis of tartrate-resistant acid phosphatase by osteoblast-like cells is followed by inactivation of the enzyme. Perez-Amodio, S.; Jansen, D.; Tigchelaar-Gutter, W.; Beertsen, W.; Everts, V.; Jansen, D C // Calcified Tissue International;Apr2006, Vol. 78 Issue 4, p248 

    Tartrate-resistant acid phosphatase (TRACP) is generally used as a marker of osteoclasts. Yet, other bone-associated cells, such as osteoblasts and osteocytes, may also express activity of this enzyme. Osteoblasts containing TRACP activity are seen particularly in the vicinity of areas of bone...

  • Osteocyte-Driven Bone Remodeling. Bellido, Teresita // Calcified Tissue International;Jan2014, Vol. 94 Issue 1, p25 

    Osteocytes, the most abundant cells in bone, have been long postulated to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. The discovery that the inhibitor of bone formation sclerostin is primarily expressed in osteocytes in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics